NCT01683695 - Safety Study of AMG 557 in Subjects With Lupus Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Lupus Arthritis, Systemic Lupus Erythematosus

Interventions

DRUG

AMG 557

AMG 557 will be administered as subcutaneous injections in the anterior abdomen of the subjects.

DRUG

Matching Placebo

Placebo will be administered as subcutaneous injections in the anterior abdomen of the subjects.

Trial Locations (13)

Research Site, St Leonards

Research Site, Odense

Research Site, Taipei

Research Site, Berlin

Research Site, Manhasset

Research Site, Lille

Research Site, Kuala Lumpur

Research Site, Los Angeles

Research Site, Kuching

Research Site, San Leandro

Research Site, Danbury

Research Site, Birmingham

Research Site, London